[HTML][HTML] Systematic genomic and clinical analysis of severe acute respiratory syndrome coronavirus 2 reinfections and recurrences involving the same strain

C Rodríguez-Grande, L Alcalá, A Estévez… - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.

C Rodriguez-Grande, L Alcala, A Estevez… - Emerging Infectious …, 2022 - go.gale.com
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.

C Rodríguez-Grande, L Alcalá, A Estévez… - Emerging Infectious …, 2021 - europepmc.org
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

[引用][C] Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

C Rodríguez-Grande, L Alcalá… - Emerging …, 2022 - produccioncientifica.ucm.es
Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome
Coronavirus 2 Reinfections and Recurrences Involving the Same Strain | Documentos …

Systematic genomic and clinical analysis of Severe acute respiratory syndrome coronavirus 2 reinfections and recurrences involving the same strain.

C Rodríguez-Grande, L Alcalá, A Estévez… - 2022 - cabidigitallibrary.org
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.

C Rodríguez-Grande, L Alcalá… - Emerging Infectious …, 2022 - search.ebscohost.com
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

C Rodríguez-Grande, L Alcalá… - Emerging …, 2022 - pubmed.ncbi.nlm.nih.gov
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

C Rodríguez-Grande, L Alcalá… - Emerging Infectious …, 2022 - search.proquest.com
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

C Rodríguez-Grande, L Alcalá, A Estévez… - Emerging Infectious …, 2022 - stacks.cdc.gov
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain

C Rodríguez-Grande, L Alcalá, A Estévez… - 2022 - digital.csic.es
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …